Friday, November 20, 2009
Print Current Session:
|
|
Friday
SESSION XXII:
INTERVENTIONAL ONCOLOGY: LIVER AND CANCER METASTASES
Moderators:Sarah Bellemare, MD / Jeff F. Geschwind, MD
|
|
SESSION XXII SCHEDULE | |
1:00 PM - 1:10 PM | Liver Transplant And The Interventional Radiologist |
Presenters(s):Paul J. Gaglio, MD | |
1:10 PM - 1:20 PM | UNOS Criteria For Liver Transplantation: How It Effects Choice Of Surgery vs. Local Regional Therapy |
Presenters(s):Milan Kinkhabwala, MD | |
1:20 PM - 1:30 PM | Percutaneous Management Of Post Liver Transplant Complications |
Presenters(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR | |
1:30 PM - 1:40 PM | Volumetric Measurements And Portal Vein Embolization To Facilitate Partial Hepatectomy |
Presenters(s):Michael Wallace, MD | |
1:40 PM - 1:50 PM | CO2 DSA For Interventional Oncology |
Presenters(s):James Caridi, MD | |
1:50 PM - 2:00 PM | PRECISION V Study: Conventional TACE vs. DC Beads For Treatment Of HCC: A Randomized Trial |
Presenters(s):Johannes Lammer, MD | |
2:00 PM - 2:10 PM | RFA For HCC |
Presenters(s):Jeffrey S. Pollak, MD | |
2:10 PM - 2:20 PM | Cyberknife vs. Percutaneous Ablation Techniques: Results In Lung And Liver Tumors |
Presenters(s):Nishita Kothary, MD | |
2:20 PM - 2:30 PM | Percutaneous Hepatic Artery Infusion Of Chemotherapy With Venous Filtration: The Delcath System |
Presenters(s):Elliot Levy, MD | |
2:30 PM - 2:40 PM | IRE: Is It The Holy Grail For The Treatment Of Pancreatic Cancer? |
Presenters(s):Lawrence V. Hofmann, MD | |
2:40 PM - 2:50 PM | Fiducial Implantation For Sterotactic Radiotherapy: How I Do It |
Presenters(s):Nishita Kothary, MD | |
2:50 PM - 3:00 PM | Drug Eluting Beads: The Italian Experience Using Combined Therapy |
Presenters(s):James Caridi, MD | |
3:00 PM - 3:10 PM | Bland Embolization And RFA At Same Session: Advantages And Disadvantages |
Presenters(s):Franco Orsi, MD | |
3:10 PM - 3:20 PM | Hepatic Arterial Management Of Metastatic Neuroendocrine Tumors |
Presenters(s):Karen T. Brown, MD | |
3:20 PM - 3:30 PM | Y90 Embolization For Hepatic Metastases |
Presenters(s):Michael C. Cohn, MS, MD | |
3:30 PM - 3:40 PM | Tissue Characteristics After Ablation (RF, Cryo, MW, IRE) Of Liver Tumors: Is There Prognostic Value? |
Presenters(s):Constantinos T. Sofocleous, MD, PhD | |
3:40 PM - 3:50 PM | Interventional Oncology + Molecular Imaging = The Future Of Cancer Therapy |
Presenters(s):Lawrence V. Hofmann, MD | |
3:50 PM - 4:00 PM | What, If Any Interventional Oncology Procedures Can Be Done In An Outpatient Setting? |
Presenters(s):Thomas O. McNamara, MD | |
4:00 PM - 4:10 PM | The Future Of Interventional Oncology |
Presenters(s):Jeff F. Geschwind, MD | |
4:10 PM - 4:20 PM | Panel Discussion And Closing Remarks |
4:20 PM - 4:20 PM | Adjourn |
END OF SESSION XXII | |
previous |